Thinking of joining a study?

Register your interest

NCT03094026 | RECRUITING | Cognitive Impairment


Cognitive Training Intervention and Attitudes Towards Genetics
Sponsor:

University of Alabama at Birmingham

Information provided by (Responsible Party):

Noah Mohamed Sharafilding

Brief Summary:

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Condition or disease

Cognitive Impairment

Hematologic Neoplasms

Hematopoietic Cell Transplant

Intervention/treatment

Lumosity

Lumosity (waitlist control)

Phase

NA

Detailed Description:

The investigators propose using an "off-the-shelf" product - Lumosity (http://www.lumosity.com/) - an online cognitive training program, to address the cognitive impairment in outpatient HCT survivors. The program offers over 60 tasks in game-like format that cover the main cognitive domains: processing speed, working memory, and executive function. Training will involve a daily session of 5 training tasks for 12 weeks. Each time the patient is logged in for a session, a customized report will be generated by the Lumosity program to capture performance information. Ideally, targeting the intervention and offering it specifically to those at highest risk (integrating clinical and genetic markers) would ensure efficacy. However, evidence is lacking on whether patients are receptive to communication of individual genetic information and whether provision of such results would lead to enhanced intervention response. To realize the high expectations of personalized medicine, patients' preferences and attitudes need to be thoroughly investigated especially as more information on genetic risk becomes available. The investigators will examine patients' genetic knowledge to determine whether factual knowledge of genetics is essential for understanding genetic risk and for informing treatment decision making in this patient population.

Study Type : INTERVENTIONAL
Estimated Enrollment : 60 participants
Masking : NONE
Primary Purpose : SUPPORTIVE_CARE
Official Title : Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation
Actual Study Start Date : 2017-08-21
Estimated Primary Completion Date : 2026-07
Estimated Study Completion Date : 2026-07

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 21 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * ≥ 21 years old at time of allogeneic HCT performed at UAB
  • * Outpatient and between 3 and 6 months post HCT
  • * English speaking
  • * Possess access to an internet-connected home computer
  • Exclusion criteria
    • * History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
    • * Participated in neuropsychological intervention within the past 6 months
    • * History of color blindness

Cognitive Training Intervention and Attitudes Towards Genetics

Location Details

NCT03094026


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Albama

University of Alabama at Birmingham

Birmingham, Albama, United States, 35233

Loading...